Remember those people who said they didn’t want to get COVID-19 vaccines that were not fully approved by the Food and Drug Administration?
Vaccination numbers appear to indicate that approval didn’t change many of their minds.
Recommended Videos
[TRENDING: Tropical wave could bring rain to Fla. | Roommate fight leaves 1 dead, 2 hurt | Become a News 6 Insider]
Pfizer saw an increase in demand for its vaccine after it received full FDA approval, but it was modest and short-lived.
In the week following that full approval, Pfizer vaccination rates rose by 16%.
During the same time, rates for Moderna’s vaccine, which still only has emergency use approval, rose by 5%.
In subsequent weeks, demand for both has fallen.